Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bugworks Research

Bugworks Research
2014 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$3M LATEST DEAL AMOUNT
16 INVESTORS
Description

Developer of drugs for the treatment of antibiotic resistant bacterial infections. The company discovers antibiotics for the treatment of antibiotic resistant bacterial infections using systems biology, structural biology and medicinal chemistry in order to reduce efflux mediated drug resistance.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 2711 Centerville Road
  • Suite 400
  • Wilmington, DE 19808
  • United States

+1 (818) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bugworks Research’s full profile, request a free trial.

Bugworks Research Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 08-Dec-2018 $3M 000.00 Completed Generating Revenue
5. Early Stage VC (Series A) 13-Aug-2018 000 000.00 0000 Completed Generating Revenue
4. Grant 27-Jul-2017 00.00 00.000 Completed Generating Revenue
3. Seed Round 20-Nov-2015 00.000 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 19-Jul-2014 Completed Generating Revenue
1. Grant 04-Feb-2014 $2.4M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Bugworks Research Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 3,537,819 $0.000100 $1.7 $1.7 1x $1.7 14.73%
Seed 4,126,230 $0.000100 $0.63 $0.63 1x $0.63 17.63%
To view this company’s complete Cap Table, request access »

Bugworks Research Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Destiny Pharma Formerly VC-backed Brighton, United Kingdom 0 000.00 00000000 000.00
00 00000000 Private Debt Financed Paris, France 00 000.00 000000000 000.00
0000000 0000000000 Venture Capital-Backed Cambridge, United Kingdom 00000 000000000 00000
000000000 Venture Capital-Backed Stevenage, United Kingdom 00 000.00 00000000000 000.00
00000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Bugworks Research Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
3one4 Capital Venture Capital Minority 000 0000 000000 0
Acquipharma Venture Capital Minority 000 0000 000000 0
Baxter Ventures Corporate Venture Capital Minority 000 0000 000000 0
The University of Tokyo Edge Capital Venture Capital Minority 000 0000 000000 0
CARB-X Government 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Bugworks Research Executive Team (7)

Name Title Board
Seat
Contact
Info
Anand Anandkumar Ph.D Co-Founder & Chief Executive Officer
V Balasubramanian Co-Founder, President, Research & Development, Executive Director
Santanu Datta Ph.D Co-Founder, Executive Director & Chief Scientific Officer
Shahul Hameed Vice President, Discovery

3 Former Executives

You’re viewing 4 of 7 executives. Get the full list »

Bugworks Research Board Members (1)

Name Representing Role Since Contact
Info
Atsushi Usami Ph.D The University of Tokyo Edge Capital Board Member 000 0000